Skip to main content

Philip Morris International Inc.

corporate_fare Company Profile

Philip Morris International Inc.

PM·NYSE·Trade & Services·CIK 0001413329

Philip Morris International Inc. is a Virginia holding company incorporated in 1987, which became a U.S. public company listed on the New York Stock Exchange in March 2008. The company is a leading international consumer goods company focused on delivering a smoke-free future and expanding its portfolio beyond tobacco and nicotine. Its current product portfolio primarily includes cigarettes and smoke-free products such as heat-not-burn, nicotine pouch, and e-vapor products. Since 2008, the company has invested over $16 billion to develop, scientifically substantiate, and commercialize innovative smoke-free products for adult smokers, aiming to end cigarette sales. This investment includes building scientific assessment capabilities in pre-clinical systems toxicology, clinical and behavioral research, and post-market studies. In November 2022, Philip Morris International acquired Swedish Match AB, a leader in oral nicotine delivery, forming a global smoke-free combination featuring the IQOS and ZYN brands. As of April 30, 2024, the company holds full rights to commercialize IQOS in the U.S. The U.S. Food and Drug Administration (FDA) has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches, and versions of PMI's IQOS devices and consumables, which were the first such authorizations in their categories. Versions of IQOS devices and consumables and General snus also received the first-ever Modified Risk Tobacco Product (MRTP) authorizations from the FDA. Philip Morris International also has a long-term ambition to expand into wellness areas, leveraging its foundation and expertise in life sciences.

Philip Morris International Inc. (NYSE:PM) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 34 items for PM at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Philip Morris Raises FY Adjusted EPS Outlook to $8.31-$8.46
  • US FDA Regulatory Shift to Boost Philip Morris' Zyn Sales by Millions
  • Philip Morris International Appoints Massimo Andolina as New CFO, Emmanuel Babeau Transitions to Advisor
  • Philip Morris International Finalizes $1.5 Billion Two-Part Notes Offering
  • Philip Morris Files for Two-Part Notes Offering, Size Undisclosed

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$40.65B
Net Income
$11.35B
Diluted EPS
$7.26
Op. Cash Flow
$12.23B
Free Cash Flow
$10.66B
Gross Profit
$27.28B
Operating Income
$14.89B
Cash & Equivalents
$4.87B
Total Debt
$168M
Debt / Equity
-0.02×
Net Margin
27.9%
Shares Outstanding
1.56B sh
Source: 10-K · filed 2026-02-06 · accession 0001628280-26-005939
$187.46
52-week range · as of 2026-09-08 $142.11 – $207.76
Market cap
$292.18B
Volume
3.1M (0.7× avg)
3-mo avg 4.2M
Live data · 2026-10-05 05:09 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed PM - Filings & News (Page 2)

PM
Jun 02, 2026, 1:31 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $172.62
Real-time Price: $187.46 info
Change: +$14.84 (+9%) info
Market Cap: $292.178B info
PM
May 26, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $187.76
Real-time Price: $187.46 info
Change: -$0.300 (-0.16%) info
Market Cap: $292.178B info
PM
May 20, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $191.00
Real-time Price: $187.46 info
Change: -$3.54 (-2%) info
Market Cap: $292.178B info
PM
Apr 27, 2026, 6:12 PM EDT
Filing Type: FWP
Importance Score:
7
Price at Filing: $161.14
Real-time Price: $187.46 info
Change: +$26.32 (+16%) info
Market Cap: $292.178B info
PM
Apr 27, 2026, 8:24 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $163.02
Real-time Price: $187.46 info
Change: +$24.44 (+15%) info
Market Cap: $292.178B info
PM
Apr 24, 2026, 7:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $167.49
Real-time Price: $187.46 info
Change: +$19.97 (+12%) info
Market Cap: $292.178B info
PM
Apr 24, 2026, 7:09 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $168.90
Real-time Price: $187.46 info
Change: +$18.56 (+11%) info
Market Cap: $292.178B info
PM
Apr 22, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $153.20
Real-time Price: $187.46 info
Change: +$34.26 (+22%) info
Market Cap: $292.178B info
PM
Apr 22, 2026, 6:59 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $153.33
Real-time Price: $187.46 info
Change: +$34.13 (+22%) info
Market Cap: $292.178B info
PM
Apr 01, 2026, 7:35 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $165.34
Real-time Price: $187.46 info
Change: +$22.12 (+13%) info
Market Cap: $292.178B info
PM
Feb 18, 2026, 10:04 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $183.07
Real-time Price: $187.46 info
Change: +$4.39 (+2%) info
Market Cap: $292.178B info
PM
Feb 06, 2026, 7:14 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $178.00
Real-time Price: $187.46 info
Change: +$9.46 (+5%) info
Market Cap: $292.178B info
PM
Feb 06, 2026, 7:02 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $180.18
Real-time Price: $187.46 info
Change: +$7.28 (+4%) info
Market Cap: $292.178B info
PM
Jan 15, 2026, 8:36 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $170.47
Real-time Price: $187.46 info
Change: +$16.99 (+10%) info
Market Cap: $292.178B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets